![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
20
Union Quimico Farmaceutica, S.a. (uquifa S.a.) Barcelona Es, based in Spain, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Lamotrigine, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2010-382 - Rev 04
This Chemical Type CEP, issued on October 28, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1756 associated with this CEP further emphasizes